Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
- PMID: 28182564
- DOI: 10.1183/13993003.00214-2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Erratum in
-
"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary." Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha and Alvar Agusti. Eur Respir J 2017; 49: 1700214.Eur Respir J. 2017 Jun 22;49(6):1750214. doi: 10.1183/13993003.50214-2017. Print 2017 Jun. Eur Respir J. 2017. PMID: 28642306 No abstract available.
Abstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.
Copyright ©2017 the American Thoracic Society. Published with permission from the American Thoracic Society. Design and branding are copyright ©ERS 2017.
Similar articles
-
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP. Am J Respir Crit Care Med. 2017. PMID: 28128970
-
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7. Respirology. 2017. PMID: 28150362
-
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6. Arch Bronconeumol. 2017. PMID: 28274597 English, Spanish.
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9. Am J Respir Crit Care Med. 2013. PMID: 22878278 Review.
-
The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?Clin Respir J. 2012 Oct;6(4):208-14. doi: 10.1111/crj.12002. Clin Respir J. 2012. PMID: 22906068 Review.
Cited by
-
Association of Physical Activity with Asthma and Chronic Obstructive Pulmonary Disease and Mediation of Frailty: Mendelian Randomization Analyses.Int J Chron Obstruct Pulmon Dis. 2024 Oct 16;19:2309-2320. doi: 10.2147/COPD.S475714. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39429808 Free PMC article.
-
Brazilian version of the Clinical COPD Questionnaire, administered by interview: reliability and validity measurement properties.J Bras Pneumol. 2021 May 31;47(3):e20200371. doi: 10.36416/1806-3756/e20200371. eCollection 2021. J Bras Pneumol. 2021. PMID: 34076173 Free PMC article.
-
Promoting Health Literacy and Perceived Self-Efficacy in People with Chronic Obstructive Pulmonary Disease.Iran J Nurs Midwifery Res. 2022 Aug 9;27(4):331-336. doi: 10.4103/ijnmr.ijnmr_34_21. eCollection 2022 Jul-Aug. Iran J Nurs Midwifery Res. 2022. PMID: 36275341 Free PMC article.
-
Erchen decoction combined with Sanziyangqin decoction for chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 Oct 2;99(40):e22315. doi: 10.1097/MD.0000000000022315. Medicine (Baltimore). 2020. PMID: 33019407 Free PMC article.
-
Chronic obstructive pulmonary disease and lung cancer: access to palliative care, emergency room visits and hospital deaths.BMC Pulm Med. 2021 May 19;21(1):170. doi: 10.1186/s12890-021-01533-3. BMC Pulm Med. 2021. PMID: 34011344 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical